Cardiovascular Devices Segment to Lead Cardiac Monitoring Devices Market During 2021-2028
According to the latest study on 'Cardiac Monitoring Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Product Type, Application, and End User,' the market is expected to grow from US$ 10.52 million in 2021 to US$ 16.43 million by 2028; it is estimated to grow at a CAGR of 6.6% from 2021 to 2028. The report highlights the key factors and trends impacting the North America cardiac monitoring devices market, and focuses on prominent players and their strategies.
A cardiac event monitor is a device that is used to record the heart's electrical activity, i.e., ECG. It keeps track of the heartbeat and rhythm. When there is a need for long-term monitoring of symptoms that don't happen every day, cardiac event monitors are employed. Important heart health data can be tracked, recorded, and sent to the doctor in real-time using cardiac monitoring systems. This reduces the need for frequent visits to the doctor's office, allowing the care team to monitor heart health remotely. An increase in the incidence of cardiovascular diseases, a surge in the geriatric population base, and a rise in the number of product launches and approvals propel the growth of the cardiac monitoring devices market. However, the risk of associated cybersecurity vulnerabilities limits the North America cardiac monitoring devices market growth.
Based on type, the cardiac monitoring devices market is segmented into cardiovascular devices, patient monitoring devices, multi-parameter ECG monitors, cardiac monitors, ambulatory cardiac monitoring, and others. The cardiovascular devices segment held the largest market share in 2021. However, the patient monitoring devices segment is anticipated to register the highest CAGR during the forecast period. Cardiovascular devices are important for the systemic management of patients with severe cardiovascular diseases (CVD), including vascular disease and heart disease. According to the American Heart Association, almost half of the adult population in the US have a type of CVD. Furthermore, more than 130 million people, i.e., 45.1%, of the US population, are expected to have a type of CVD by 2035. As per the Centers for Diseases Control and Prevention (CDC), every year ~655,000 Americans die from heart disease. To lower the death rate due to CVDs, a cardiovascular device used in the cardiac care department is available in general hospitals. A variety of cardiac care equipment used in CICU includes cardiac monitors, stress test systems, EKG (Electrocardiogram) equipment, heart-lung bypass machines, intra-aortic balloon pumps, AEDs, infusion pumps, and defibrillators.
Medtronic; Abbott; Boston Scientific Corporation; iRhythm Technologies, Inc.; GE Healthcare; Biotronik, Inc.; SCHILLER Healthcare India Pvt. Ltd; Koninklijke Philips N.V.; MicroPort Scientific Corporation; Asahi Kasei Corporation; Hill-Rom Holdings, Inc.; Nihon Kohden Corporation; AliveCor, Inc; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; ACS Diagnostics; BTL; Hemodynamics Company LLC; Mortara Instruments; LivaNova PLC; TZ Medical; Amiitalia; RHYTHMEDIX; and Medi-Lynx Cardiac Monitoring, LLC; are among the key players operating in the cardiac monitoring devices market.
The North America cardiac monitoring devices market is analyzed on the basis of type, product type, application and end user. Based on type, the market is categorized into cardiovascular devices (event monitors, electrocardiography (ECG), cardiac catheters, stents, defibrillators, guidewires, pacemakers, heart valves and others), patient monitoring devices (cardio monitoring devices, anesthesia monitoring devices, hemodynamic monitoring devices, fetal and neonatal monitoring devices, stress management devices and others), multi-parameter ECG monitors, cardiac monitors [cardiac event monitoring (CEM) holter, extended holter/AECG, and others], ambulatory cardiac monitoring (event recorders, implantable loop recorders, mobile cardiac telemetry, and others), and others. Based on product type, the North America cardiac monitoring devices market is segmented into the standard monitor, portable monitor, and smart wearable monitor. Based on application, the North America cardiac monitoring devices market is segmented into coronary heart diseases, stroke, sudden cardiac arrest, arrhythmia, heart failure, pulmonary hypertension, congenital heart diseases, pulmonary artery pressure (PA), heart function (HF/LVEDP), and Others. Based on end user, the market is segmented into hospitals, clinics, ambulatory surgery centers, cardiac centers, home care, and others. The North America cardiac monitoring devices, by country, is segmented into the US, Canada, and Mexico.
Reasons to Buy
According to the latest study on 'Cardiac Monitoring Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Product Type, Application, and End User,' the market is expected to grow from US$ 10.52 million in 2021 to US$ 16.43 million by 2028; it is estimated to grow at a CAGR of 6.6% from 2021 to 2028. The report highlights the key factors and trends impacting the North America cardiac monitoring devices market, and focuses on prominent players and their strategies.
A cardiac event monitor is a device that is used to record the heart's electrical activity, i.e., ECG. It keeps track of the heartbeat and rhythm. When there is a need for long-term monitoring of symptoms that don't happen every day, cardiac event monitors are employed. Important heart health data can be tracked, recorded, and sent to the doctor in real-time using cardiac monitoring systems. This reduces the need for frequent visits to the doctor's office, allowing the care team to monitor heart health remotely. An increase in the incidence of cardiovascular diseases, a surge in the geriatric population base, and a rise in the number of product launches and approvals propel the growth of the cardiac monitoring devices market. However, the risk of associated cybersecurity vulnerabilities limits the North America cardiac monitoring devices market growth.
Based on type, the cardiac monitoring devices market is segmented into cardiovascular devices, patient monitoring devices, multi-parameter ECG monitors, cardiac monitors, ambulatory cardiac monitoring, and others. The cardiovascular devices segment held the largest market share in 2021. However, the patient monitoring devices segment is anticipated to register the highest CAGR during the forecast period. Cardiovascular devices are important for the systemic management of patients with severe cardiovascular diseases (CVD), including vascular disease and heart disease. According to the American Heart Association, almost half of the adult population in the US have a type of CVD. Furthermore, more than 130 million people, i.e., 45.1%, of the US population, are expected to have a type of CVD by 2035. As per the Centers for Diseases Control and Prevention (CDC), every year ~655,000 Americans die from heart disease. To lower the death rate due to CVDs, a cardiovascular device used in the cardiac care department is available in general hospitals. A variety of cardiac care equipment used in CICU includes cardiac monitors, stress test systems, EKG (Electrocardiogram) equipment, heart-lung bypass machines, intra-aortic balloon pumps, AEDs, infusion pumps, and defibrillators.
Medtronic; Abbott; Boston Scientific Corporation; iRhythm Technologies, Inc.; GE Healthcare; Biotronik, Inc.; SCHILLER Healthcare India Pvt. Ltd; Koninklijke Philips N.V.; MicroPort Scientific Corporation; Asahi Kasei Corporation; Hill-Rom Holdings, Inc.; Nihon Kohden Corporation; AliveCor, Inc; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; ACS Diagnostics; BTL; Hemodynamics Company LLC; Mortara Instruments; LivaNova PLC; TZ Medical; Amiitalia; RHYTHMEDIX; and Medi-Lynx Cardiac Monitoring, LLC; are among the key players operating in the cardiac monitoring devices market.
The report segments the cardiac monitoring devices market as follows:
The North America cardiac monitoring devices market is analyzed on the basis of type, product type, application and end user. Based on type, the market is categorized into cardiovascular devices (event monitors, electrocardiography (ECG), cardiac catheters, stents, defibrillators, guidewires, pacemakers, heart valves and others), patient monitoring devices (cardio monitoring devices, anesthesia monitoring devices, hemodynamic monitoring devices, fetal and neonatal monitoring devices, stress management devices and others), multi-parameter ECG monitors, cardiac monitors [cardiac event monitoring (CEM) holter, extended holter/AECG, and others], ambulatory cardiac monitoring (event recorders, implantable loop recorders, mobile cardiac telemetry, and others), and others. Based on product type, the North America cardiac monitoring devices market is segmented into the standard monitor, portable monitor, and smart wearable monitor. Based on application, the North America cardiac monitoring devices market is segmented into coronary heart diseases, stroke, sudden cardiac arrest, arrhythmia, heart failure, pulmonary hypertension, congenital heart diseases, pulmonary artery pressure (PA), heart function (HF/LVEDP), and Others. Based on end user, the market is segmented into hospitals, clinics, ambulatory surgery centers, cardiac centers, home care, and others. The North America cardiac monitoring devices, by country, is segmented into the US, Canada, and Mexico.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the cardiac monitoring devices market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America cardiac monitoring devices market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
Table of Contents
1. Introduction
3. Research Methodology
4. North America Cardiac Monitoring Devices Market - Market Landscape
5. North America Cardiac Monitoring Devices Market - Key Market Dynamics
6. Cardiac Monitoring Devices Market - North America Analysis
7. North America Cardiac Monitoring Devices Market Revenue and Forecasts To 2028- by Type
8. Cardiac Monitoring Devices Market Revenue and Forecasts To 2028 - Product Type
9. Cardiac Monitoring Devices Market Revenue and Forecasts To 2028 - Application
10. Cardiac Monitoring Devices Market Revenue and Forecasts To 2028 - End User
11. North America Cardiac Monitoring Devices Market- Country Analysis
12. Impact of COVID-19 Pandemic on North America Cardiac Monitoring Devices Market
13. Company Profiles
14. Appendix
List of Tables
List of Figures
Executive Summary
The North America cardiac monitoring devices market is expected to reach US$ 16.43 billion by 2028 from US$ 10.52 billion in 2021. It is estimated to grow at a CAGR of 6.6% from 2021 to 2028.the market growth is attributed to an increase in the incidence of cardiovascular diseases, a surge in the geriatric population base, and a rise in the number of product launches and approvals. However, the risk of associated cybersecurity vulnerabilities and privacy issues hamper the market growth.
A cardiac event monitor is used to record the heart's electrical activity (ECG). It keeps the track of the heartbeat and rhythm. These monitors are employed for the long-term monitoring of symptoms that don't occur every day. Important heart health data can be tracked, recorded, and sent to patients’ doctors in real time using cardiac monitoring systems, allowing the care teams to monitor patients’ heart health from a distance. This reduces the need for frequent visits to the doctor's office.
In the last decade, the world has witnessed notable developments in cardiac monitoring devices, offering physicians and patients new approaches to manage many diseases, including atrial arrhythmias, ventricular arrhythmias, and ventricular atrial fibrillation. The growing prevalence of cardiovascular diseases (CVDs), such as coronary heart diseases, sudden cardiac arrest, congenital heart diseases, heart failure, pulmonary hypertension, and pulmonary artery pressure (PA), is encouraging the introduction of improved monitoring methods. The simplicity of use and the ability of a quick detection of CVDs are the factors adding to the popularity of cardiac monitoring devices. According to the World Health Organization (WHO), ~30 million people experience a stroke each year. Moreover, the American Heart Association states more than 130 million people in the US, i.e., 45.1% of the population, are projected to have a type of CVD by 2035.
Type Insights
Based on type, the North America cardiac monitoring devices market is segmented into cardiovascular devices, multi-parameter ECG monitors, patient monitoring devices, ambulatory cardiac monitoring, and cardiac monitors. In 2020, the cardiovascular devices segment held the largest share of the market. The market for the patient monitoring devices segment is expected to grow at the highest CAGR during the period from 2021 to 2028. With a growing prevalence of chronic disorders such as stroke, coronary heart disease, sudden cardiac arrest, and congenital heart diseases, the demand for patient monitoring devices is increasing. Temperature monitoring, continuous glucose monitoring, and pulsed oximetry blood pressure monitoring are several applications of wearable patient monitoring, biosensors, and smart implants.
Product Type Insights
Based on product type, the North America cardiac monitoring devices market is segmented into portable monitor, smart wearable monitor, and standard monitor. In 2020, the standard monitor segment held the largest share of the market. Moreover, the market for the smart wearable monitor segment is expected to grow at the fastest CAGR during 2021-2028. The PMMA is a plastic with excellent mechanical properties and minimal toxicity. The growing trend encourages the usage of commercial smart wearable monitors for health management. In the era of remote and personalized patient care, especially catalyzed by the COVID-19 pandemic, there is a high demand for wearable technologies for a wide range of clinical applications.
Application Insights
Based on application, the North America cardiac monitoring devices market is segmented into coronary heart diseases, sudden cardiac arrest, stroke, arrhythmia, congenital heart diseases, heart failure, pulmonary hypertension, heart function (HF/LVEDP), pulmonary artery pressure (PA), and others. The coronary heart diseases segment held the largest market share in 2020, and it is further expected to be the largest shareholder in the market by 2028. The increased prevalence of diabetes, hypertension, and high cholesterol levels is contributing to the growing risk of cardiovascular disease and accelerating the cases of coronary heart diseases.
End User Insights
Based on end user, the North America cardiac monitoring devices market is segmented into hospitals, ambulatory surgery centers (ASCs), and clinics. The hospitals segment held the largest market share in 2020, and it is further expected to be the largest shareholder in the market by 2028. Hospitals are the primary healthcare centers where cardiovascular diseases, including coronary heart diseases, stroke, sudden cardiac arrest, and arrhythmia, are extensively treated.
A few major primary and secondary sources referred to while preparing the report on the North America cardiac monitoring devices market are the World Health Organization (WHO), American Heart Association, Centers for Diseases Control and Prevention (CDC), World Heart Federation, AND National Center for Biotechnology Information (NCBI).
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Medtronic
- Abbott
- Boston Scientific Corporation
- Irhythm Technologies, Inc.
- GE Healthcare
- Biotronik, Inc.
- Schiller Healthcare India Pvt. Ltd
- Koninklijke Philips N.V.
- Microport Scientific Corporation
- Asahi Kasei Corporation
- Hill-Rom Holdings, Inc.
- Nihon Kohden Corporation
- Alivecor, Inc
- Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
- Acs Diagnostics
- Btl
- Hemodynamics Company LLC
- Mortara Instruments
- Livanova plc
- Tz Medical
- Amiitalia
- Rhythmedix
- Medi-Lynx Cardiac Monitoring, LLC
- Infinium Medical
- Bionet America, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 320 |
| Published | March 2022 |
| Forecast Period | 2021 - 2028 |
| Estimated Market Value ( USD | $ 10523.79 Million |
| Forecasted Market Value ( USD | $ 16431.31 Million |
| Compound Annual Growth Rate | 6.6% |
| Regions Covered | North America |
